{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:31:19Z","timestamp":1791729079036,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ebiom.2024.105231","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T20:00:36Z","timestamp":1719950436000},"page":"105231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering"],"prefix":"10.1016","volume":"105","author":[{"given":"Christopher","family":"Nelke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1391-7817","authenticated-orcid":false,"given":"Christina B.","family":"Schroeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumanta","family":"Barman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Stascheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Masanneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Theissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Huntemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Walli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Dobelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vogelsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pawlitzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"R\u00e4uber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix F.","family":"Konen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skripuletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6332-8650","authenticated-orcid":false,"given":"Tobias","family":"Ruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2024.105231_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105231_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-022-02448-4","article-title":"Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients","volume":"19","author":"Nelke","year":"2022","journal-title":"J\u00a0Neuroinflammation"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105231_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11940-020-00632-6","article-title":"Myasthenia gravis treatment updates","volume":"22","author":"Cort\u00e9s-Vicente","year":"2020","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105231_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100066","article-title":"Terminal complement inhibitor ravulizumab in generalized myasthenia gravis","volume":"1","author":"Vu","year":"2022","journal-title":"NEJM Evid"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105231_bib5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13311-021-01175-7","article-title":"Neonatal Fc receptor-targeted therapies in neurology","volume":"19","author":"Nelke","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105231_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105231_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/pro.3307","article-title":"The human protein atlas: a spatial map of the human proteome","volume":"27","author":"Thul","year":"2018","journal-title":"Protein Sci"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105231_bib8","doi-asserted-by":"crossref","first-page":"942","DOI":"10.15252\/msb.20156297","article-title":"Revisiting biomarker discovery by plasma proteomics","volume":"13","author":"Geyer","year":"2017","journal-title":"Mol Syst Biol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105231_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cels.2021.06.006","article-title":"Artificial intelligence for proteomics and biomarker discovery","volume":"12","author":"Mann","year":"2021","journal-title":"Cell Syst"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105231_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.anchem.1.031207.112942","article-title":"Mass spectrometry\u2013based biomarker discovery: toward a global proteome index of individuality","volume":"2","author":"Hawkridge","year":"2009","journal-title":"Annu Rev Anal Chem"},{"key":"10.1016\/j.ebiom.2024.105231_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/978-1-4939-7057-5_31","article-title":"Mass spectrometry-based serum proteomics for biomarker discovery and validation","volume":"1619","author":"Bhosale","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105231_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12014-023-09424-x","article-title":"Mass spectrometry-based proteomics as an emerging tool in clinical laboratories","volume":"20","author":"Birhanu","year":"2023","journal-title":"Clin Proteom"},{"key":"10.1016\/j.ebiom.2024.105231_bib13","series-title":"Deutsche Gesellschaft f\u00fcr Neurologie e. V. LL 68-ll-diagnostik und therapie der myasthenia gravis und des lambert-eaton-syndroms","year":"2014"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105231_bib14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jnnp-2021-328665","article-title":"Eculizumab versus rituximab in generalised myasthenia gravis","volume":"93","author":"Nelke","year":"2022","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105231_bib15","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105231_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/CND.0b013e31824619d5","article-title":"The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers","volume":"13","author":"Barnett","year":"2012","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105231_bib17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105231_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00432-014-1817-x","article-title":"Protein deep sequencing applied to biobank samples from patients with pancreatic cancer","volume":"141","author":"Ansari","year":"2015","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105231_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa1146","article-title":"cola: an R\/Bioconductor package for consensus partitioning through a general framework","volume":"49","author":"Gu","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2024.105231_bib20","article-title":"Isolation of primary murine skeletal muscle microvascular endothelial cells","author":"M\u00fcntefering","year":"2019","journal-title":"J\u00a0Vis Exp"},{"issue":"21","key":"10.1016\/j.ebiom.2024.105231_bib21","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2591","article-title":"Isolation of primary human skeletal muscle cells","volume":"7","author":"Spinazzola","year":"2017","journal-title":"Bio Protoc"},{"issue":"18","key":"10.1016\/j.ebiom.2024.105231_bib22","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105231_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105231_bib24","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.ebiom.2024.105231_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.169135","article-title":"Eculizumab treatment alters the proteometabolome beyond the inhibiton of complement","volume":"8","author":"Nelke","year":"2023","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105231_bib26","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1021\/acs.jproteome.7b00353","article-title":"Digging more missing proteins using an enrichment approach with ProteoMiner","volume":"16","author":"Li","year":"2017","journal-title":"J\u00a0Proteome Res"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105231_bib27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/srep00336","article-title":"Consensus clustering in complex networks","volume":"2","author":"Lancichinetti","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2024.105231_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.524413","article-title":"The usage of human IGHJ genes follows a particular non-random selection: the recombination signal sequence may affect the usage of human IGHJ genes","volume":"11","author":"Shi","year":"2020","journal-title":"Front Genet"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105231_bib29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.immuni.2023.02.003","article-title":"B\u00a0cell receptor signaling in germinal centers prolongs survival and primes B cells for selection","volume":"56","author":"Chen","year":"2023","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105231_bib30","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001169","article-title":"Heterogeneity of acetylcholine receptor autoantibody\u2013mediated complement activity in patients with myasthenia gravis","volume":"9","author":"Obaid","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105231_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0022-510X(80)90085-4","article-title":"Acetylcholine receptors in cultured human muscle cells","volume":"47","author":"Franklin","year":"1980","journal-title":"J\u00a0Neurol Sci"},{"issue":"23","key":"10.1016\/j.ebiom.2024.105231_bib32","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.3390\/cells11233760","article-title":"Alignment of skeletal muscle cells facilitates acetylcholine receptor clustering and neuromuscular junction formation with Co-cultured human iPSC-derived motor neurons","volume":"11","author":"Shimizu","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105231_bib33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105231_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108787","article-title":"Proteogenomics of glioblastoma associates molecular patterns with survival","volume":"34","author":"Yanovich-Arad","year":"2021","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105231_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/mus.26910","article-title":"Correlation of quantitative myasthenia gravis and myasthenia gravis activities of daily living scales in the MGTX study","volume":"62","author":"McPherson","year":"2020","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105231_bib36","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1002\/mus.26152","article-title":"Correlation between myasthenia gravis-activities of daily living (MG-ADL) and quantitative myasthenia gravis (QMG) assessments of anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis in the phase 3 regain study","volume":"58","author":"Vissing","year":"2018","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105231_bib37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/mus.25529","article-title":"QMG and MG-ADL correlations: study of eculizumab treatment of myasthenia gravis","volume":"56","author":"Howard","year":"2017","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105231_bib38","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/ene.15730","article-title":"Complement activation profiles in anti-acetylcholine receptor positive myasthenia gravis","volume":"30","author":"Stascheit","year":"2023","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105231_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264489","article-title":"Myasthenia gravis complement activity is independent of autoantibody titer and disease severity","volume":"17","author":"Fichtner","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2024.105231_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1177249","article-title":"Clinical and immune-related factors associated with exacerbation in adults with well-controlled generalized myasthenia gravis","volume":"14","author":"Bi","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105231_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105231_bib42","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1172\/JCI82695","article-title":"Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity","volume":"125","author":"Quast","year":"2015","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105231_bib43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00401-022-02493-6","article-title":"Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities","volume":"144","author":"Rose","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105231_bib44","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41590-019-0325-1","article-title":"BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer\u2019s patches","volume":"20","author":"Biram","year":"2019","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105231_bib45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/mus.23944","article-title":"Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?","volume":"49","author":"Sanders","year":"2014","journal-title":"Muscle Nerve"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424002664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424002664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T06:48:16Z","timestamp":1728283696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424002664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":45,"alternative-id":["S2352396424002664"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105231","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105231"}}